1. Home
  2. CAE vs HALO Comparison

CAE vs HALO Comparison

Compare CAE & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAE
  • HALO
  • Stock Information
  • Founded
  • CAE 1947
  • HALO 1998
  • Country
  • CAE Canada
  • HALO United States
  • Employees
  • CAE N/A
  • HALO N/A
  • Industry
  • CAE
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CAE
  • HALO Health Care
  • Exchange
  • CAE Nasdaq
  • HALO Nasdaq
  • Market Cap
  • CAE 8.4B
  • HALO 7.6B
  • IPO Year
  • CAE N/A
  • HALO N/A
  • Fundamental
  • Price
  • CAE $26.20
  • HALO $76.07
  • Analyst Decision
  • CAE Buy
  • HALO Buy
  • Analyst Count
  • CAE 4
  • HALO 8
  • Target Price
  • CAE $33.25
  • HALO $70.25
  • AVG Volume (30 Days)
  • CAE 685.0K
  • HALO 2.1M
  • Earning Date
  • CAE 08-12-2025
  • HALO 10-30-2025
  • Dividend Yield
  • CAE N/A
  • HALO N/A
  • EPS Growth
  • CAE N/A
  • HALO 68.93
  • EPS
  • CAE 0.95
  • HALO 4.37
  • Revenue
  • CAE $3,471,030,749.00
  • HALO $1,178,672,000.00
  • Revenue This Year
  • CAE $5.06
  • HALO $32.57
  • Revenue Next Year
  • CAE $5.98
  • HALO $23.25
  • P/E Ratio
  • CAE $27.64
  • HALO $17.40
  • Revenue Growth
  • CAE 8.99
  • HALO 34.97
  • 52 Week Low
  • CAE $17.48
  • HALO $42.01
  • 52 Week High
  • CAE $30.13
  • HALO $76.28
  • Technical
  • Relative Strength Index (RSI)
  • CAE 33.58
  • HALO 81.50
  • Support Level
  • CAE $26.27
  • HALO $72.39
  • Resistance Level
  • CAE $26.80
  • HALO $76.28
  • Average True Range (ATR)
  • CAE 0.45
  • HALO 1.66
  • MACD
  • CAE -0.05
  • HALO 0.00
  • Stochastic Oscillator
  • CAE 0.34
  • HALO 96.89

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: